{"public_id":"cl_2d30e06c32753ce11efeac7be03415dc","status":"active","superseded_by_public_id":null,"corpus_id":22826405,"text":"Rapid-acting insulin analogues showed similarly small hemoglobin A1c differences compared with regular human insulin in type 2 diabetes.","confidence":0.96,"paper":{"corpus_id":22826405,"title":"Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis","url":"https://sah.borca.ai/papers/22826405"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.96,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1239da7d221e8cd03b9e2c268618cea6","name":"rapid-acting insulin analogues","description":"Insulin analogues designed for fast onset of glucose-lowering action around meals.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_1239da7d221e8cd03b9e2c268618cea6"},{"public_id":"co_2f08e9e81da7c89f711793e0bffe0096","name":"regular human insulin","description":"A short-acting human insulin preparation used as a comparator for rapid-acting insulin analogues.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_2f08e9e81da7c89f711793e0bffe0096"},{"public_id":"co_b2910c3e2393810fdc0f23a47c720b22","name":"hemoglobin A1c","description":"A blood biomarker reflecting average long-term glycemic control.","types":["outcome"],"url":"https://sah.borca.ai/concepts/co_b2910c3e2393810fdc0f23a47c720b22"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_2d30e06c32753ce11efeac7be03415dc"}